News & Updates

Statin use linked to reduced risk of severe COVID-19 outcomes
Statin use linked to reduced risk of severe COVID-19 outcomes
06 Nov 2022 byRoshini Claire Anthony

Patients who are on long-term statin therapy may have a reduced risk of severe COVID-19–related outcomes including mortality, intensive care unit (ICU) admission, and requirement for mechanical ventilation, according to a study presented at Anesthesiology 2022.

Statin use linked to reduced risk of severe COVID-19 outcomes
06 Nov 2022
Third-dose vaccine beats tolerance in cirrhotic COVID-19 patients
Third-dose vaccine beats tolerance in cirrhotic COVID-19 patients
06 Nov 2022

A third-dose administration of a COVID-19 mRNA vaccine results in a more substantial decrease in COVID-19 in patients with cirrhosis compared with the general population, according to a study. This suggests that the third dose can overcome vaccine hyporesponsiveness in this population.

Third-dose vaccine beats tolerance in cirrhotic COVID-19 patients
06 Nov 2022
Tuberculosis doubles risk of death in patients on ART
Tuberculosis doubles risk of death in patients on ART
06 Nov 2022

Coinfection of tuberculosis (TB) among people with HIV initiating antiretroviral therapy (ART) aggravates the risk of death, a recent study has found.

Tuberculosis doubles risk of death in patients on ART
06 Nov 2022
Slow disease progression seen in people with NAFLD
Slow disease progression seen in people with NAFLD
05 Nov 2022